Jane Street’s Opus Genetics IRD Stock Holding History

Jane Street’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$197K	Buy	+43,400	New	+$150K	﹤0.01%	10165

Other funds holding IRD

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jane Street's IRD Position: Q1 2026 in Review

Jane Street opened a new position in Opus Genetics (IRD) in Q1 2026: 158,103 shares worth $719K. The stake represents ﹤0.01% of the portfolio and ranks #7219 among its holdings. This is a return to the name: Jane Street previously reported a position in IRD as recently as Q4 2024.

Jane Street first reported a position in IRD in Q2 2018 and has held it in 7 quarters since. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

Jane Street held 158,103 shares of Opus Genetics worth $719K as of Q1 2026.
Opus Genetics was a new Jane Street position in Q1 2026.
Opus Genetics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7219 holding.
Jane Street first reported a position in Opus Genetics in Q2 2018 and has held it in 7 quarters since.
79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.